Gloria Freixas-Vilches

Maastricht, LI 6229ET, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A posteriori and predictive interplay evaluation methodology for lung and esophageal cancer patients treated in free breathing with IMPT.

A posteriori and predictive interplay evaluation methodology for lung and esophageal cancer patients treated in free breathing with IMPT.

Journal: Physics in medicine and biology

Published: June 10, 2026

Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol.

Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 02, 2026

Radiation therapy and cancer during pregnancy - Current practice in the Netherlands.

Radiation therapy and cancer during pregnancy - Current practice in the Netherlands.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 24, 2025

Evaluation of proton range differences in photon-counting and dual-energy computed tomography across imaging doses and anthropomorphic phantom sizes.

Evaluation of proton range differences in photon-counting and dual-energy computed tomography across imaging doses and anthropomorphic phantom sizes.

Journal: Physics in medicine and biology

Published: December 17, 2025

Dosimetric comparison of the shoulder region between paired photon and proton plans in breast cancer patients.

Dosimetric comparison of the shoulder region between paired photon and proton plans in breast cancer patients.

Journal: Technical innovations & patient support in radiation oncology

Published: November 28, 2025

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma.

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma.

Journal: Physics and imaging in radiation oncology

Published: September 25, 2025

A posterioriand predictive interplay evaluation methodology for lung and esophageal cancer patients treated in free breathing with IMPT.

A posterioriand predictive interplay evaluation methodology for lung and esophageal cancer patients treated in free breathing with IMPT.

Journal: Physics in medicine and biology

Published: September 23, 2025

Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer.

Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer.

Journal: Physics and imaging in radiation oncology

Published: September 22, 2025

Validation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer.

Validation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer.

Journal: Physics in medicine and biology

Published: September 15, 2025

Practical considerations for handling implants in proton therapy.

Practical considerations for handling implants in proton therapy.

Journal: Journal of applied clinical medical physics

Published: July 07, 2025

Case Report: Proton Therapy of a Pregnant Patient With Small-Cell Lung Cancer in the Third Trimester Using Synthetic Computed Tomographies for Tumor Monitoring.

Case Report: Proton Therapy of a Pregnant Patient With Small-Cell Lung Cancer in the Third Trimester Using Synthetic Computed Tomographies for Tumor Monitoring.

Journal: Advances in radiation oncology

Published: June 27, 2025

Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 20, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026